Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1849 1
1894 1
1966 1
1967 2
1969 1
1974 1
1976 1
1977 1
1981 1
1982 1
1986 2
1988 2
1992 2
1993 1
1994 1
1996 1
1997 1
1998 1
1999 1
2002 1
2004 2
2005 2
2006 4
2007 3
2008 2
2009 2
2010 2
2011 6
2012 5
2013 9
2014 5
2015 4
2016 6
2017 2
2018 4
2019 5
2020 10
2021 7
2022 11
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Life cycle of a cyanobacterial carboxysome.
Hill NC, Tay JW, Altus S, Bortz DM, Cameron JC. Hill NC, et al. Among authors: cameron jc. Sci Adv. 2020 May 6;6(19):eaba1269. doi: 10.1126/sciadv.aba1269. eCollection 2020 May. Sci Adv. 2020. PMID: 32494723 Free PMC article.
Public policy for meningococcal vaccination.
Cameron JC. Cameron JC. Hum Vaccin Immunother. 2018 May 4;14(5):1216-1217. doi: 10.1080/21645515.2017.1403701. Epub 2018 Jan 16. Hum Vaccin Immunother. 2018. PMID: 29194013 Free PMC article.
Mechanical regulation of photosynthesis in cyanobacteria.
Moore KA, Altus S, Tay JW, Meehl JB, Johnson EB, Bortz DM, Cameron JC. Moore KA, et al. Among authors: cameron jc. Nat Microbiol. 2020 May;5(5):757-767. doi: 10.1038/s41564-020-0684-2. Epub 2020 Mar 23. Nat Microbiol. 2020. PMID: 32203409
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.
Shaw RH, Greenland M, Stuart ASV, Aley PK, Andrews NJ, Cameron JC, Charlton S, Clutterbuck EA, Collins AM, Darton T, Dinesh T, Duncan CJA, Faust SN, Ferreira DM, Finn A, Goodman AL, Green CA, Hallis B, Heath PT, Hill H, Lambe T, Libri V, Lillie PJ, Morey E, Mujadidi YF, Payne R, Plested EL, Provstgaard-Morys S, Ramasamy MN, Ramsay M, Read RC, Robinson H, Screaton GR, Singh N, Turner DPJ, Turner PJ, White R, Nguyen-Van-Tam JS, Liu X, Snape MD; Com-COV2 Study Group. Shaw RH, et al. Among authors: cameron jc. J Infect. 2023 Jun;86(6):574-583. doi: 10.1016/j.jinf.2023.03.027. Epub 2023 Apr 6. J Infect. 2023. PMID: 37028454 Free PMC article. Clinical Trial.
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial.
Kelly E, Greenland M, de Whalley PCS, Aley PK, Plested EL, Singh N, Koleva S, Tonner S, Macaulay GC, Read RC, Ramsay M, Cameron JC, Turner DPJ, Heath PT, Bernatoniene J, Connor P, Cathie K, Faust SN, Banerjee I, Cantrell L, Mujadidi YF, Belhadef HT, Clutterbuck EA, Anslow R, Valliji Z, James T, Hallis B, Otter AD, Lambe T, Nguyen-Van-Tam JS, Minassian AM, Liu X, Snape MD; Com-COV3 Study Group. Kelly E, et al. Among authors: cameron jc. J Infect. 2023 Sep;87(3):230-241. doi: 10.1016/j.jinf.2023.06.007. Epub 2023 Jun 17. J Infect. 2023. PMID: 37331429 Free PMC article. Clinical Trial.
104 results